Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51,136,131
-
Number of holders
-
160
-
Total 13F shares, excl. options
-
28,922,545
-
Shares change
-
-638,949
-
Total reported value, excl. options
-
$936,893,202
-
Value change
-
-$29,109,226
-
Put/Call ratio
-
93%
-
Number of buys
-
66
-
Number of sells
-
-95
-
Price
-
$32.38
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q1 2020
205 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q1 2020.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 160 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28,922,545 shares
of 51,136,131 outstanding shares and own 57% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5,034,689 shares), VANGUARD GROUP INC (3,544,905 shares), Redmile Group, LLC (2,338,466 shares), STATE STREET CORP (1,966,563 shares), JPMORGAN CHASE & CO (1,503,346 shares), DIMENSIONAL FUND ADVISORS LP (686,799 shares), GOLDMAN SACHS GROUP INC (637,805 shares), WS MANAGEMENT LLLP (635,761 shares), UBS Group AG (625,625 shares), and PERCEPTIVE ADVISORS LLC (508,000 shares).
This table shows the top 160 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.